Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Xiao‐Zhou He"'
Autor:
Zhen Qu, Ke-jia Wu, Jia-wei Feng, Ding-sen Shi, Yu-xiang Chen, Dong-lin Sun, Yun-Fei Duan, Jing Chen, Xiao-zhou He
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
With the improvement of laparoscopic surgery, the feasibility and safety of laparoscopic hepatectomy have been affirmed, but intraoperative hepatic venous system hemorrhage and carbon dioxide gas embolism are the difficulties in laparoscopic hepatect
Externí odkaz:
https://doaj.org/article/a51158c8a2a04d4d998b43e0204c2576
Autor:
Hao Jiang, Jing-Yuan Tang, Dong Xue, Yi-Meng Chen, Ting-Chun Wu, Qian-Feng Zhuang, Xiao-Zhou He
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Renal cell carcinoma (RCC) is a clinically common tumor in the urinary system, showing an upward trend of both incidence and mortality. Apolipoprotein C1 (APOC1) has been identified as a vital regulator in tumor progression. This
Externí odkaz:
https://doaj.org/article/70ae216357db4fa88277f7404f587be5
Autor:
Zhen Qu, Yun-jie Lu, Jia-Wei Feng, Yu-xiang Chen, Long-qing Shi, Jing Chen, Navin Rambaran, Yun-Fei Duan, Xiao-zhou He
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Increasing evidence indicates that preoperative prognostic indices can serve as independent predictors of survival in patients with cancer. However, the applicability of these indices in patients with hepatocellular carcinoma (HCC) is controversial.
Externí odkaz:
https://doaj.org/article/13f571e5b2b84fca93f84b8f93897963
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4836-4844 (2019)
Abstract High‐throughput sequencing methods have facilitated the identification of novel selenoproteins, which exert a vital role in the development and progression of tumor diseases. Recently, Selenoprotein M (SELM) is upregulated in several types
Externí odkaz:
https://doaj.org/article/f94e0f326d704ed599f487f6a3166bf5
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Hypoxia and ischemia are the main underlying pathogenesis of stroke and other neurological disorders. Cerebral hypoxia and/or ischemia (e.g., stroke) can lead to neuronal injury/death and eventually cause serious neurological disorders or even death
Externí odkaz:
https://doaj.org/article/56decf87d5e442879f74074416195528
Publikováno v:
Cellular Physiology and Biochemistry, Vol 50, Iss 2, Pp 640-653 (2018)
Background/Aims: Mammalian target of rapamycin (mTOR) is a valuable treatment target of renal cell carcinoma (RCC). Palomid 529 is a novel mTORC1/2 dual inhibitor. Methods: RCC cells were treated with different concentrations of Palomid 529. Cell sur
Externí odkaz:
https://doaj.org/article/445edcee679343f38b8b53fe6540d794
Publikováno v:
Asian Journal of Andrology, Vol 20, Iss 4, Pp 366-371 (2018)
We evaluated the prognosis of the new grade groups and American Joint Committee on Cancer (AJCC) stage groups in men with prostate cancer (PCa) who were treated conservatively. A total of 13 798 eligible men were chosen from the Surveillance Epidemio
Externí odkaz:
https://doaj.org/article/a208036c59f14f07ad7832f06491c682
Autor:
Xing Wang, Bo Shang, Jin cheng Hao, Zhao liang Wang, Hui ling Jing, Kai lin Yang, Yan jun Cao, Xiao zhou He
Publikováno v:
Journal of Affective Disorders. 294:189-199
Background Prenatal stress (PS) can cause brain retardation, reduce the learning and memory ability of the offspring and significantly increase the incidence of depression in offspring. Paeoniflorin (PF), a kind of monoterpenoid glycoside, is one of
Autor:
Zhen Qu, Yun-jie Lu, Jia-Wei Feng, Yu-xiang Chen, Long-qing Shi, Jing Chen, Navin Rambaran, Yun-Fei Duan, Xiao-zhou He
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Increasing evidence indicates that preoperative prognostic indices can serve as independent predictors of survival in patients with cancer. However, the applicability of these indices in patients with hepatocellular carcinoma (HCC) is controversial.
Autor:
hao jiang, Jing-Yuan Tang, Dong Xue, Yi-Meng Chen, Ting-Chun Wu, Qian-Feng Zhuang, Xiao-Zhou He
Background Renal cell carcinoma (RCC) is a clinically common tumor in the urinary system, showing an upward trend of both incidence and mortality. Apolipoprotein C1 (APOC1) has been identified as a vital regulator in tumor progression. This study aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17aafaa89876e61b2ff97e16bc6acaae
https://doi.org/10.21203/rs.3.rs-29010/v3
https://doi.org/10.21203/rs.3.rs-29010/v3